Home › Kanser sa Prostate › Virginia › Richmond
Pag-aaral pangklinika para sa Kanser sa Prostate sa Richmond, VA
19 pag-aaral para sa Kanser sa Prostate ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng Richmond (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
The Vanguard Study: Testing a New Way to Screen for Cancer
Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
- VCU Massey Cancer Center at Stony Point, Richmond
- VCU Massey Comprehensive Cancer Center, Richmond
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
Nagre-recruitPhase 3
- VCU Massey Cancer Center at Stony Point, Richmond
- VCU Massey Comprehensive Cancer Center, Richmond
Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
Nagre-recruitPhase 2
- Bon Secours Richmond Community Hospital, Richmond
- Bon Secours Saint Mary's Hospital, Richmond
- Bon Secours Cancer Institute at Reynolds Crossing, Richmond
- at 4 pa
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
- Bon Secours Richmond Community Hospital, Richmond
- Bon Secours Saint Mary's Hospital, Richmond
- Bon Secours Cancer Institute at Reynolds Crossing, Richmond
- at 3 pa
Autonomic and Renal Contributions to Hypertension With ADT
Nagre-recruitPhase 4Malugod na tinatanggap ang malusog na boluntaryo
- Virginia Commonwealth University, Richmond
Barrigel® PPRT (Post-Prostatectomy Radiation Therapy) Trial
Nagre-recruit
- Virginia Urology Center, Richmond
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
Nagre-recruitPhase 3
- VCU Health Adult Outpatient Pavillion ( Site 0061), Richmond
A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
Nagre-recruitPhase 3
- Bon Secours Cancer Institute at Saint Francis, Midlothian · 11 mi ang layo
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Nagre-recruitPhase 3
- Bon Secours Saint Mary's Hospital, Richmond
- Bon Secours Cancer Institute at Reynolds Crossing, Richmond
- VCU Massey Cancer Center at Stony Point, Richmond
- at 4 pa
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
Nagre-recruitPhase 3
- VCU Massey Comprehensive Cancer Center, Richmond
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
Nagre-recruitPhase 3
- Bon Secours Richmond Community Hospital, Richmond
- Bon Secours Saint Mary's Hospital, Richmond
- Bon Secours Cancer Institute at Reynolds Crossing, Richmond
- at 2 pa
TERPS Trial for de Novo Oligometastic Prostate Cancer
Nagre-recruitPhase 2
- Bon Secours Cancer Institute at St. Francis, Midlothian · 11 mi ang layo
Androgen Suppression Combined With Nodal Irradiation and Dose Escalated Prostate Treatment
Nagre-recruitPhase 3
- Bon Secours Cancer Institute at Reynolds Crossing, Richmond
- VCU Massey Comprehensive Cancer Center, Richmond
- Bon Secours Saint Francis Medical Center, Midlothian · 11 mi ang layo
Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer
Nagre-recruitPhase 2/3
- Hunter Holmes McGuire VA Medical Center, Richmond, VA, Richmond
Stratagen Quantitative Prostate MRI Platform Pilot Study
Nagre-recruit
- Virginia Urology, Richmond
Behavioral Exercise Training to Reduce Cardiovascular Disease Risk
Nagre-recruitPhase 1/2
- Richmond Veterans Affairs Medical Center, Richmond
- Virginia Commonwealth University Massey Cancer Center, Richmond
Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to Cabazitaxel Alone in People With Castrate-Resistant Prostate Cancer That Has Spread Beyond the Prostate to Other Parts of the Body
Nagre-recruitPhase 3
- VCU Massey Cancer Center at Stony Point, Richmond
- Virginia Commonwealth University/Massey Cancer Center, Richmond
Vitamin D for Prostate Endocrine Therapy
Nagre-recruitPhase 3
- Bon Secours Saint Mary's Hospital, Richmond
- Bon Secours Cancer Institute at Reynolds Crossing, Richmond
- VCU Massey Cancer Center at Stony Point, Richmond
- at 3 pa
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
Nagre-recruitPhase 3
- Bon Secours Cancer Institute at Reynolds Crossing, Richmond
- VCU Massey Cancer Center at Stony Point, Richmond
- Virginia Commonwealth University/Massey Cancer Center, Richmond
- at 1 pa
Pag-aaral para sa Kanser sa Prostate sa ibang lungsod
- New York City, NY103 pag-aaral
- Houston, TX76 pag-aaral
- Los Angeles, CA61 pag-aaral
- Boston, MA59 pag-aaral
- St. Louis, MO46 pag-aaral
- Chicago, IL45 pag-aaral
- San Francisco, CA45 pag-aaral
- Philadelphia, PA44 pag-aaral
- Baltimore, MD43 pag-aaral
- Nashville, TN43 pag-aaral
- Seattle, WA42 pag-aaral
- Washington, DC38 pag-aaral
Iba pang pag-aaral sa Richmond
- Kanser sa Suso26 pag-aaral
- Non-Small Cell Lung Cancer25 pag-aaral
- Pagkabigo ng Puso16 pag-aaral
- Kanser sa Baga14 pag-aaral
- Sakit sa Puso at Ugat ng Dugo13 pag-aaral
- Colorectal Cancer13 pag-aaral
- Steatotic Liver Disease12 pag-aaral
- Acute Myeloid Leukemia12 pag-aaral
- Metastatic Cancer12 pag-aaral
- Squamous Cell Carcinoma ng Ulo at Leeg12 pag-aaral
- Melanoma11 pag-aaral
- Obesity11 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.